Blincyto

Description

Generic Name:

Blinatumomab

Description:

Blincyto is used to treat a certain type of acute lymphoblastic leukemia in adults and children.

Blincyto is given after other cancer treatments have been tried without success.

Blincyto was approved by the US Food and Drug Administration (FDA) on an “accelerated” basis. In clinical studies, some people responded to this medicine, but further studies are needed.

Acute lymphoblastic leukemia is a cancer of the blood in which a particular kind of white blood cell is growing out of control.

Indication :

Acute lymphoblastic leukemia

Dosage:

Blincyto is given around the clock (continuous) using an infusion pump. A healthcare provider will give you this injection. The medicine enters the body through a catheter placed into a vein.

You may receive your first dose of Blincyto in a hospital or clinic setting to quickly treat any serious side effects. You may also need to be in a hospital if you start using the medicine again after not using it for a short time.

Your injections will be prepared at the pharmacy and you will receive the medicine in IV bags. Keep the IV bags in their original package and do not open the package. Store it in the refrigerator, protected from light. Do not freeze. Each IV bag will be unpackaged and prepared by a healthcare provider.

Read and carefully follow any Instructions for Use provided with your medicine. Do not use Blincyto if you don’t understand all instructions for proper use. Ask your doctor or pharmacist if you have questions.

Blincyto is usually given around the clock. Your doctor will determine how often you need to use this medicine, and for how long.

Do not change the settings on your infusion pump without the assistance of a healthcare professional.

You may be given medication to prevent certain side effects while you are receiving Blincyto.

When it is time to change IV bags, call your doctor or pharmacist if you do not have a new IV bag ready to attach to the infusion pump.

Be sure to keep the skin clean around your catheter (IV) to reduce the risk of infection.

Blincyto can increase your risk of bleeding or infection by changing the way your immune system works. You will need frequent medical tests. Your cancer treatments may be delayed based on the results.

Precaution & Warnings:

Some side effects may occur during the Blincyto injection. Tell your caregiver right away if you feel dizzy, nauseated, light-headed, chilled or feverish, or if you have a headache, skin rash, trouble breathing, or swelling in your face.

A serious side effect of Blincyto is called cytokine release syndrome, which causes fever, chills, trouble breathing, vomiting, and other symptoms. Your caregivers will have medication available to quickly treat this condition if it occurs.

Also tell your caregivers or seek emergency medical attention if you have slurred speech, confusion, loss of balance, or seizure (convulsions). These could be signs of life-threatening nerve problems.

Prescription Information:

Proper doctor prescription is needed.
*Note: The prescription should not be older than 6 month.

Contraindication:

Other drugs may interact with blinatumomab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using